A new study in mice has identified new treatment targets for glaucoma, including preventing a severe pediatric form of glaucoma, as well as uncovering a possible new class of therapy for the most common form of glaucoma in adults.
In people with high pressure glaucoma, fluid in the eye doesn’t properly drain and builds up pressure on the optic nerve, leading to vision loss. It affects 60 million people worldwide and is the most common cause of blindness in people over 60 years old.
While there are a few treatments available for open angle glaucoma, the most common form of glaucoma in adults (eye drops, oral medication, laser treatments), there are no cures, and a severe form of glaucoma in children between birth and three years old known as primary congenital glaucoma can only be treated with surgery.
“Although primary congenital glaucoma is much rarer than open angle glaucoma, it is devastating for children,” said corresponding author. “New treatments and new classes of treatments are urgently needed to slow vision loss in both forms.
Using gene editing, the scientists in the study developed new models of glaucoma in mice that resembled primary congenital glaucoma. By injecting a new, long-lasting and non-toxic protein treatment (Hepta-ANGPT1) into mice, the scientists were able to replace the function of genes that, when mutated, cause glaucoma. With this injectable treatment, the scientists also successfully prevented glaucoma from ever forming in one model. This same therapy, when injected into the eyes of healthy adult mice, reduced pressure in the eyes, supporting it as a possible new class of therapy for the most common cause of glaucoma in adults (high intraocular pressure open angle glaucoma).
The study was published in the journal Nature Communications.
The next step is to develop the appropriate delivery system for the successful new protein treatment in patients and bring it to production, the author said.
Additionally, the scientists used bioinformatics and single cell RNA sequence data to understand and identify glaucoma pathways that can be explored in the future for additional therapeutic targets for the disease, such as ones that regulate communication with a specialized blood vessel in the eye (Schlemm’s canal) that is important for draining fluid and maintaining normal eye pressure.
“Having a treatment that can promote remodeling and/or growth of a defective Schlemm’s canal to treat glaucoma would be fantastic,” the author said. “These studies are the first step to that goal.
“Our hope is that this study leads to the first targeted therapy that effectively promotes (aqueous humor) fluid outflow from the front of an eye, reversing the underlying biologic defect in patients with glaucoma.”
https://www.nature.com/articles/s41467-021-26346-0
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fcellular-crosstalk&filter=22
Cellular crosstalk regulates the aqueous humor outflow pathway in glaucoma
- 1,139 views
- Added
Edited
Latest News
How our brain reacts to and…
By newseditor
Posted 08 Jul
Tissue-specific gene regula…
By newseditor
Posted 07 Jul
How hippocampus is activate…
By newseditor
Posted 07 Jul
Removal of excess chloride…
By newseditor
Posted 07 Jul
Intermittent fasting and br…
By newseditor
Posted 07 Jul
Other Top Stories
Identification of a new protein essential for ovule and sperm forma…
Read more
Heart and liver disease linked to shutdown of body's antioxidant
Read more
Underappreciated protein plays critical role in RNA regulation and…
Read more
A missing link between tau and memory loss
Read more
Regulating monocyte differentiation and atherosclerosis development
Read more
Protocols
Pan-cancer proteogenomics c…
By newseditor
Posted 05 Jul
A systems biology-based ide…
By newseditor
Posted 05 Jul
Tongue orthotopic xenograft…
By newseditor
Posted 04 Jul
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Publications
Understanding gut dysbiosis…
By newseditor
Posted 08 Jul
The immune and metabolic mi…
By newseditor
Posted 08 Jul
Body Composition in Advance…
By newseditor
Posted 08 Jul
Spatiotemporal brain hierar…
By newseditor
Posted 08 Jul
HNF4A and HNF1A exhibit tis…
By newseditor
Posted 07 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar